Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Cohen, Justin M ^a   Singh, Inder ^a   O'Brien, Megan E ^a  

^a Clinton Foundation HIV/AIDS Initiative   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTEMISIN; LACTONE;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; FUNDING; HUMAN; MALARIA; COMPARATIVE STUDY; DRUG COMBINATION; ECONOMICS; FORECASTING; HEALTH CARE COST; REGRESSION ANALYSIS; STATISTICS;

ARTEMISININS; DRUG THERAPY, COMBINATION; FORECASTING; HEALTH EXPENDITURES; LACTONES; MALARIA; REGRESSION ANALYSIS; STATISTICS AS TOPIC;

EID: 54249161841     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-200     Document Type: Article

References (29)

1. Guidelines for the treatment of malaria. WHO, Geneva: World Health Organization 2006
2. WHO, the Global Fund, and medical malpractice in malaria treatment. A Attaran KI Barnes C Curtis U d'Alessandro CI Fanello MR Galinski G Kokwaro S Looareesuwan M Makanga TK Mutabingwa, Lancet 2004 363 237 240 10.1016/S0140-6736(03)15330-5 14738799
3. The Global Fund and effective malaria treatment. J Liden VM Nantulya, Geneva, Switzerland: The Global Fund to Fight AIDS, Tuberculosis, and Malaria 2004
4. Ensuring sustained ACT production and reliable artemisinin supply. JM Kindermans J Pilloy P Olliaro M Gomes, Malar J 2007 6 125 17868471 10.1186/1475-2875-6-125
5. Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs). JM Kindermans D Vandenbergh E Vreeke P Olliaro JP D'Altilia, Malar J 2007 6 91 17623092 10.1186/1475-2875-6-91
6. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. K Arrow C Panosian H Gelband (eds), Washington (D.C.): Institute of Medicine, National Academies Press 2004 15042238
7. The process of changing national malaria treatment policy: lessons from country-level studies. HA Williams D Durrheim R Shretta, Health Policy Plan 2004 19 356 370 10.1093/heapol/czh051 15459161
8. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. A Bosman KN Mendis, Am J Trop Med Hyg 2007 77 193 197 18165492
9. Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. V Hale JD Keasling N Renninger TT Diagana, Am J Trop Med Hyg 2007 77 198 202 18165493
10. The Global Fund. Press Release - 30 November 2005. http://www. theglobalfund.org/en/media_center/press/pr_051130.asp
11. Global Forecast of ACT Demand. JM Cohen I Singh, Boston: Clinton Foundation HIV/AIDS Initiative 2008 http://www.clintonfoundation.org/what-we-do/ clinton-hiv-aids-initiative/information-center-resources
12. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation. C Lu CM Michaud K Khan CJ Murray, Lancet 2006 368 483 488 10.1016/S0140-6736(06)69156-3 16890835
13. Global Fund grant programmes: an analysis of evaluation scores. S Radelet B Siddiqi, Lancet 2007 369 1807 1813 10.1016/S0140-6736(07)60818-6 17531888
14. The Global Fund. Grants in Detail. http://www.theglobalfund.org/en/files/ grantsindetail_raw.xls
15. The Global Fund. Disbursements in detail. http://www.theglobalfund.org/ en/files/disbursementsindetail_raw.xls
16. Using regression models for prediction: shrinkage and regression to the mean. JB Copas, Stat Methods Med Res 1997 6 167 183 10.1191/096228097667367976 9261914
17. Data splitting. RR Picard KN Berk, Amer Statistician 1990 44 140 147 10.2307/2684155
18. Cross-validation of regression models. RR Picard RD Cook, J Amer Statistical Assoc 1984 79 575 583 10.2307/2288403
19. The Global Fund. Funded Programs. http://www.theglobalfund.org/programs/ search.aspx?lang=en
20. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. EM Malik TA Mohamed KA Elmardi RM Mowien AH Elhassan SB Elamin AA Mannan ES Ahmed, Malar J 2006 5 65 16879742 10.1186/1475-2875-5-65
21. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. A Amin D Zurovac B Kangwana J Greenfield D Otieno W Akhwale R Snow, Malaria Journal 2007 6 72 17535417 10.1186/1475-2875-6-72
22. Mapping and realigning incentives in the global health supply chain: based on the supply chain for artemisinin combination therapy treatments for malaria. P Yadav K Curtis N Sekhri, Zaragoza, Spain: MIT-Zaragoza International Logistics Program and The Healthcare Redesign Group Inc 2006
23. Aidspan - independent watchdog of the Global Fund and publisher of Global Fund Observer. http://www.aidspan.org
24. The World Bank. Governance Matters 2007: Worldwide Governance Indicators, 1996-2006. http://info.worldbank.org/governance/wgi/index.asp
25. Human Development Report 2006. U Nations, New York: United Nations Development Programme 2006
26. Observer Human Rights Index 1999. http://www.guardian.co.uk/rightsindex/
27. Malaria incidence estimates at country level for the year 2004 - proposed estimates and draft report. EL Korenromp, Geneva: World Health Organization, Roll Back Malaria 2005
28. WHO Statistical Information System. http://www.who.int/whosis/en/
29. CIA 2008 World Factbook. http://www.cia.gov/cia/publications/factbook